Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 17,259 | 17,759 | 17,308 | 17,699 | 14,683 |
| Cost of Goods | 6,727 | 6,891 | 6,730 | 6,889 | 5,449 |
| Gross Profit | 10,532 | 10,868 | 10,578 | 10,810 | 9,234 |
| Operating Expenses | 18,991 | 17,075 | 20,149 | 17,253 | 17,045 |
| Operating Income | -7,732 | -5,316 | -8,841 | -5,554 | -7,362 |
| Interest Expense | 0 | 9 | 15 | 12 | 19 |
| Other Income | -8 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -7,740 | -5,325 | -8,856 | -5,566 | -7,381 |
| Net Income Continuous | -7,740 | -5,325 | -8,856 | -5,566 | -7,381 |
| Net Income | $-7,740 | $-5,325 | $-8,856 | $-5,566 | $-7,381 |
| EPS Basic Total Ops | -0.11 | -0.07 | -0.13 | -0.08 | -0.12 |
| EPS Basic Continuous Ops | -0.11 | -0.08 | -0.13 | -0.08 | -0.12 |
| EPS Diluted Total Ops | -0.11 | -0.07 | -0.13 | -0.08 | -0.12 |
| EPS Diluted Continuous Ops | -0.11 | -0.08 | -0.13 | -0.08 | -0.12 |
| EBITDA(a) | $-7,482 | $-5,054 | $-8,556 | $-5,267 | $-7,081 |